Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Inner Mongolia Furui Medical Science Co Ltd

+ Add to Watchlist

300049:CH

62.800 CNY 4.600 7.90%

As of 03:00:26 ET on 03/27/2015.

Snapshot for Inner Mongolia Furui Medical Science Co Ltd (300049)

Open: 58.110 Day's Range: 58.000 - 63.800 Volume: 3,664,085
Previous Close: 58.200 52wk Range: 23.700 - 63.800 1-Yr Rtn: +107.26%

Stock Chart for 300049

No chart data available.
  • 300049:CH 62.800
  • 1D
  • 1M
  • 1Y
58.200
Interactive 300049 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300049

Current P/E Ratio (ttm) 208.6725
Estimated P/E(12/2014) 91.0145
Relative P/E vs. SZ399006 2.7315
Earnings Per Share (CNY) (ttm) 0.3010
Est. EPS (CNY) (12/2014) 0.6900
Est. PEG Ratio -
Market Cap (M CNY) 8,153.45
Shares Outstanding (M) 129.83
30 Day Average Volume 3,860,394
Price/Book (mrq) 10.1145
Price/Sale (ttm) 14.2181
Dividend Indicated Gross Yield 0.32%
Cash Dividend (CNY) 0.2000
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300049

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300049

Inner Mongolia Furui Medical Science Co Ltd. manufactures and sells hepatology C hinese medicines. The Company's products include anti-fibrosis drug, anti fatty- liver disease medicine, and liver fibrosis testing instruments.

Wang GuanyiChairmanZhang SuiyongVice Chairman/President
Lin XinExecutive VP/SecretaryShuo FeiVice President
More Company Profile & Key Executives for 300049

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil